E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 940 KRW 0.59% Market Closed
Market Cap: 436.2B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

Relative Value

The Relative Value of one EuBiologics Co Ltd stock under the Base Case scenario is 19 707.13 KRW. Compared to the current market price of 11 940 KRW, EuBiologics Co Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
19 707.13 KRW
Undervaluation 39%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
73
vs Industry
60
Median 3Y
6.5
Median 5Y
7
Industry
7.6
Forward
4.4
vs History
vs Industry
0
Median 3Y
-46.1
Median 5Y
-27
Industry
22.1
Forward
21.9
vs History
42
vs Industry
11
Median 3Y
22.4
Median 5Y
20.4
Industry
21.9
vs History
vs Industry
Median 3Y
-40.2
Median 5Y
-41.5
Industry
23.4
vs History
53
vs Industry
25
Median 3Y
3.8
Median 5Y
4.5
Industry
2.5
vs History
82
vs Industry
50
Median 3Y
6.6
Median 5Y
7.1
Industry
7.5
Forward
4.4
vs History
84
vs Industry
33
Median 3Y
14
Median 5Y
15
Industry
9.3
vs History
47
vs Industry
6
Median 3Y
62.7
Median 5Y
29.3
Industry
4.2
Forward
11.4
vs History
4
vs Industry
3
Median 3Y
-80.2
Median 5Y
-80.2
Industry
4
Forward
15.8
vs History
42
vs Industry
11
Median 3Y
22.6
Median 5Y
20.6
Industry
5.9
vs History
1
vs Industry
Median 3Y
-29.2
Median 5Y
-39.8
Industry
3.9
vs History
46
vs Industry
41
Median 3Y
3.1
Median 5Y
3.1
Industry
4.5

Multiples Across Competitors

Competitors Multiples
EuBiologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
EuBiologics Co Ltd
KOSDAQ:206650
435.3B KRW 5.1 -238.8 29.4 81.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.5 16 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 915.4 10.2 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -213.4 21 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.6 15.1 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -134.7 -108.8 -79.8
P/S Multiple
Revenue Growth P/S to Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average P/S: 3 457 240.4
5.1
96%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average P/E: 211.7
Negative Multiple: -238.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -134.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average EV/EBITDA: 18.1
29.4
181%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average EV/EBIT: 29.9
81.8
390%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top